Record Information |
---|
Version | 5.0 |
---|
Status | Detected but not Quantified |
---|
Creation Date | 2021-09-11 02:05:42 UTC |
---|
Update Date | 2021-09-26 22:59:03 UTC |
---|
HMDB ID | HMDB0248664 |
---|
Secondary Accession Numbers | None |
---|
Metabolite Identification |
---|
Common Name | N2-[2-Methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-1,3,5-triazine-2,4-diamine |
---|
Description | This compound has been identified in human blood as reported by (PMID: 31557052 ). N2-[2-methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-n4-[2-[(1-methylethyl)sulfonyl]phenyl]-1,3,5-triazine-2,4-diamine is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically N2-[2-Methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-1,3,5-triazine-2,4-diamine is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
---|
Structure | COC1=CC(=CC=C1NC1=NC(NC2=CC=CC=C2S(=O)(=O)C(C)C)=NC=N1)N1CCC(CC1)N1CCN(C)CC1 InChI=1S/C29H40N8O3S/c1-21(2)41(38,39)27-8-6-5-7-25(27)33-29-31-20-30-28(34-29)32-24-10-9-23(19-26(24)40-4)36-13-11-22(12-14-36)37-17-15-35(3)16-18-37/h5-10,19-22H,11-18H2,1-4H3,(H2,30,31,32,33,34) |
---|
Synonyms | Not Available |
---|
Chemical Formula | C29H40N8O3S |
---|
Average Molecular Weight | 580.75 |
---|
Monoisotopic Molecular Weight | 580.294408354 |
---|
IUPAC Name | N2-{2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl}-N4-[2-(propane-2-sulfonyl)phenyl]-1,3,5-triazine-2,4-diamine |
---|
Traditional Name | N2-{2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl}-N4-[2-(propane-2-sulfonyl)phenyl]-1,3,5-triazine-2,4-diamine |
---|
CAS Registry Number | Not Available |
---|
SMILES | COC1=CC(=CC=C1NC1=NC(NC2=CC=CC=C2S(=O)(=O)C(C)C)=NC=N1)N1CCC(CC1)N1CCN(C)CC1 |
---|
InChI Identifier | InChI=1S/C29H40N8O3S/c1-21(2)41(38,39)27-8-6-5-7-25(27)33-29-31-20-30-28(34-29)32-24-10-9-23(19-26(24)40-4)36-13-11-22(12-14-36)37-17-15-35(3)16-18-37/h5-10,19-22H,11-18H2,1-4H3,(H2,30,31,32,33,34) |
---|
InChI Key | MGGBYMDAPCCKCT-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Classification | Not classified |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | | Show more...
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
N2-[2-Methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-1,3,5-triazine-2,4-diamine,1TMS,isomer #1 | COC1=CC(N2CCC(N3CCN(C)CC3)CC2)=CC=C1N(C1=NC=NC(NC2=CC=CC=C2S(=O)(=O)C(C)C)=N1)[Si](C)(C)C | 4742.6 | Semi standard non polar | 33892256 | N2-[2-Methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-1,3,5-triazine-2,4-diamine,1TMS,isomer #1 | COC1=CC(N2CCC(N3CCN(C)CC3)CC2)=CC=C1N(C1=NC=NC(NC2=CC=CC=C2S(=O)(=O)C(C)C)=N1)[Si](C)(C)C | 4464.8 | Standard non polar | 33892256 | N2-[2-Methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-1,3,5-triazine-2,4-diamine,1TMS,isomer #1 | COC1=CC(N2CCC(N3CCN(C)CC3)CC2)=CC=C1N(C1=NC=NC(NC2=CC=CC=C2S(=O)(=O)C(C)C)=N1)[Si](C)(C)C | 7000.6 | Standard polar | 33892256 | N2-[2-Methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-1,3,5-triazine-2,4-diamine,1TMS,isomer #2 | COC1=CC(N2CCC(N3CCN(C)CC3)CC2)=CC=C1NC1=NC=NC(N(C2=CC=CC=C2S(=O)(=O)C(C)C)[Si](C)(C)C)=N1 | 4713.0 | Semi standard non polar | 33892256 | N2-[2-Methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-1,3,5-triazine-2,4-diamine,1TMS,isomer #2 | COC1=CC(N2CCC(N3CCN(C)CC3)CC2)=CC=C1NC1=NC=NC(N(C2=CC=CC=C2S(=O)(=O)C(C)C)[Si](C)(C)C)=N1 | 4554.7 | Standard non polar | 33892256 | N2-[2-Methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-1,3,5-triazine-2,4-diamine,1TMS,isomer #2 | COC1=CC(N2CCC(N3CCN(C)CC3)CC2)=CC=C1NC1=NC=NC(N(C2=CC=CC=C2S(=O)(=O)C(C)C)[Si](C)(C)C)=N1 | 6927.1 | Standard polar | 33892256 | N2-[2-Methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-1,3,5-triazine-2,4-diamine,2TMS,isomer #1 | COC1=CC(N2CCC(N3CCN(C)CC3)CC2)=CC=C1N(C1=NC=NC(N(C2=CC=CC=C2S(=O)(=O)C(C)C)[Si](C)(C)C)=N1)[Si](C)(C)C | 4596.2 | Semi standard non polar | 33892256 | N2-[2-Methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-1,3,5-triazine-2,4-diamine,2TMS,isomer #1 | COC1=CC(N2CCC(N3CCN(C)CC3)CC2)=CC=C1N(C1=NC=NC(N(C2=CC=CC=C2S(=O)(=O)C(C)C)[Si](C)(C)C)=N1)[Si](C)(C)C | 4624.2 | Standard non polar | 33892256 | N2-[2-Methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-1,3,5-triazine-2,4-diamine,2TMS,isomer #1 | COC1=CC(N2CCC(N3CCN(C)CC3)CC2)=CC=C1N(C1=NC=NC(N(C2=CC=CC=C2S(=O)(=O)C(C)C)[Si](C)(C)C)=N1)[Si](C)(C)C | 6341.9 | Standard polar | 33892256 | N2-[2-Methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-1,3,5-triazine-2,4-diamine,1TBDMS,isomer #1 | COC1=CC(N2CCC(N3CCN(C)CC3)CC2)=CC=C1N(C1=NC=NC(NC2=CC=CC=C2S(=O)(=O)C(C)C)=N1)[Si](C)(C)C(C)(C)C | 4923.2 | Semi standard non polar | 33892256 | N2-[2-Methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-1,3,5-triazine-2,4-diamine,1TBDMS,isomer #1 | COC1=CC(N2CCC(N3CCN(C)CC3)CC2)=CC=C1N(C1=NC=NC(NC2=CC=CC=C2S(=O)(=O)C(C)C)=N1)[Si](C)(C)C(C)(C)C | 4695.3 | Standard non polar | 33892256 | N2-[2-Methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-1,3,5-triazine-2,4-diamine,1TBDMS,isomer #1 | COC1=CC(N2CCC(N3CCN(C)CC3)CC2)=CC=C1N(C1=NC=NC(NC2=CC=CC=C2S(=O)(=O)C(C)C)=N1)[Si](C)(C)C(C)(C)C | 7000.4 | Standard polar | 33892256 | N2-[2-Methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-1,3,5-triazine-2,4-diamine,1TBDMS,isomer #2 | COC1=CC(N2CCC(N3CCN(C)CC3)CC2)=CC=C1NC1=NC=NC(N(C2=CC=CC=C2S(=O)(=O)C(C)C)[Si](C)(C)C(C)(C)C)=N1 | 4896.4 | Semi standard non polar | 33892256 | N2-[2-Methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-1,3,5-triazine-2,4-diamine,1TBDMS,isomer #2 | COC1=CC(N2CCC(N3CCN(C)CC3)CC2)=CC=C1NC1=NC=NC(N(C2=CC=CC=C2S(=O)(=O)C(C)C)[Si](C)(C)C(C)(C)C)=N1 | 4779.4 | Standard non polar | 33892256 | N2-[2-Methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-1,3,5-triazine-2,4-diamine,1TBDMS,isomer #2 | COC1=CC(N2CCC(N3CCN(C)CC3)CC2)=CC=C1NC1=NC=NC(N(C2=CC=CC=C2S(=O)(=O)C(C)C)[Si](C)(C)C(C)(C)C)=N1 | 6927.0 | Standard polar | 33892256 | N2-[2-Methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-1,3,5-triazine-2,4-diamine,2TBDMS,isomer #1 | COC1=CC(N2CCC(N3CCN(C)CC3)CC2)=CC=C1N(C1=NC=NC(N(C2=CC=CC=C2S(=O)(=O)C(C)C)[Si](C)(C)C(C)(C)C)=N1)[Si](C)(C)C(C)(C)C | 4956.4 | Semi standard non polar | 33892256 | N2-[2-Methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-1,3,5-triazine-2,4-diamine,2TBDMS,isomer #1 | COC1=CC(N2CCC(N3CCN(C)CC3)CC2)=CC=C1N(C1=NC=NC(N(C2=CC=CC=C2S(=O)(=O)C(C)C)[Si](C)(C)C(C)(C)C)=N1)[Si](C)(C)C(C)(C)C | 5081.5 | Standard non polar | 33892256 | N2-[2-Methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-1,3,5-triazine-2,4-diamine,2TBDMS,isomer #1 | COC1=CC(N2CCC(N3CCN(C)CC3)CC2)=CC=C1N(C1=NC=NC(N(C2=CC=CC=C2S(=O)(=O)C(C)C)[Si](C)(C)C(C)(C)C)=N1)[Si](C)(C)C(C)(C)C | 6281.8 | Standard polar | 33892256 |
| Show more...
---|
Spectra |
---|
| MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N2-[2-Methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-1,3,5-triazine-2,4-diamine 10V, Positive-QTOF | splash10-001i-0001090000-e646198bd00ac479b57f | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N2-[2-Methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-1,3,5-triazine-2,4-diamine 20V, Positive-QTOF | splash10-001j-1226490000-df7887775a11ee62e49e | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N2-[2-Methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-1,3,5-triazine-2,4-diamine 40V, Positive-QTOF | splash10-0006-3594430000-5661a806008185f36256 | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N2-[2-Methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-1,3,5-triazine-2,4-diamine 10V, Negative-QTOF | splash10-004i-0123090000-8fc85ed215c6b9fc618c | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N2-[2-Methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-1,3,5-triazine-2,4-diamine 20V, Negative-QTOF | splash10-004v-3495070000-73550433df5ce1a2cb55 | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N2-[2-Methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-1,3,5-triazine-2,4-diamine 40V, Negative-QTOF | splash10-0006-5595840000-58fa1076a1befaa411e0 | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N2-[2-Methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-1,3,5-triazine-2,4-diamine 10V, Positive-QTOF | splash10-001i-0000090000-4f22b53ae216b3738512 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N2-[2-Methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-1,3,5-triazine-2,4-diamine 20V, Positive-QTOF | splash10-001i-0000190000-624cc852dc9c4bfbacf5 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N2-[2-Methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-1,3,5-triazine-2,4-diamine 40V, Positive-QTOF | splash10-00xv-6723690000-9c6a1abd74e710482fc8 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N2-[2-Methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-1,3,5-triazine-2,4-diamine 10V, Negative-QTOF | splash10-004i-0000090000-d6312a67f31d57607c4c | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N2-[2-Methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-1,3,5-triazine-2,4-diamine 20V, Negative-QTOF | splash10-004i-0000290000-05ec049b3d0a373d13d4 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N2-[2-Methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-1,3,5-triazine-2,4-diamine 40V, Negative-QTOF | splash10-004i-5121190000-9a7973a44fea734c2403 | 2021-10-12 | Wishart Lab | View Spectrum |
| Show more...
---|
Biological Properties |
---|
Cellular Locations | Not Available |
---|
Biospecimen Locations | |
---|
Tissue Locations | Not Available |
---|
Pathways | |
---|
Normal Concentrations |
---|
| |
Blood | Detected but not Quantified | Not Quantified | Not Specified | Not Specified | Normal | | details |
|
---|
Abnormal Concentrations |
---|
| Not Available |
---|
Associated Disorders and Diseases |
---|
Disease References | None |
---|
Associated OMIM IDs | None |
---|
External Links |
---|
External Links | Not Available |
---|
References |
---|
Synthesis Reference | Not Available |
---|
Material Safety Data Sheet (MSDS) | Not Available |
---|
General References | - Barupal DK, Fiehn O: Generating the Blood Exposome Database Using a Comprehensive Text Mining and Database Fusion Approach. Environ Health Perspect. 2019 Sep;127(9):97008. doi: 10.1289/EHP4713. Epub 2019 Sep 26. [PubMed:31557052 ]
|
---|